Involved-node radiotherapy and modern radiation treatment techniques in patients with Hodgkin lymphoma

International Journal of Radiation Oncology Biology Physics

Volumn 80, Issue 1, 2011, Pages 199-205

  Paumier, Amaury ^a   Ghalibafian, Mithra ^a   Beaudre, Anne ^a   Ferreira, Ivaldo ^a   Pichenot, Charlotte ^a   Messai, Taha ^a   Lessard, Nathalie Athalie ^a   Lefkopoulos, Dimitri ^a   Girinsky, Theodore ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Deep inspiration breath hold radiotherapy; Hodgkin's lymphoma; Intensity modulated radiation therapy; Involved node radiotherapy

Indexed keywords

ADRIAMYCIN; BLEOMYCINS; BREATH-HOLD; CLINICAL OUTCOME; CONFIDENCE INTERVAL; DACARBAZINE; DEEP-INSPIRATION BREATH-HOLD RADIOTHERAPY; HODGKIN'S LYMPHOMA; IN-FIELD; INTENSITY-MODULATED RADIATION THERAPY; INTENSITY-MODULATED RADIOTHERAPY; INVOLVED-NODE RADIOTHERAPY; MEDIAN RADIATION; ORGANS AT RISKS; OVERALL SURVIVAL RATES; RADIATION TREATMENTS; THREE-DIMENSIONAL CONFORMAL RADIOTHERAPY; VINBLASTINE;

CHEMOTHERAPY; DOSIMETRY; ONCOLOGY; PATIENT MONITORING; PHYSICAL THERAPY; POPULATION STATISTICS; RADIATION; THREE DIMENSIONAL;

RADIOTHERAPY;

BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DACARBAZINE; DEXAMETHASONE; DOXORUBICIN; FLUORODEOXYGLUCOSE F 18; PREDNISONE; PROCARBAZINE; THYROID HORMONE; VINBLASTINE; VINCRISTINE;

ACUTE TOXICITY; ADOLESCENT; ADULT; AGED; ARTICLE; BREATH HOLDING; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CLINICAL ARTICLE; COMPUTED TOMOGRAPHY SCANNER; CONTRAST ENHANCEMENT; DEEP INSPIRATION BREATH HOLD RADIOTHERAPY; DOSIMETRY; FEMALE; FOLLOW UP; HODGKIN DISEASE; HUMAN; HYPOTHYROIDISM; INTENSITY MODULATED RADIATION THERAPY; INVOLVED NODE RADIOTHERAPY; IRRADIATION; LUNG TOXICITY; LYMPH NODE; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PNEUMONIA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE; SPIROMETER; TREATMENT OUTCOME; TREATMENT PLANNING; TREATMENT RESPONSE;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; COMBINED MODALITY THERAPY; DACARBAZINE; DISEASE-FREE SURVIVAL; DOXORUBICIN; HODGKIN DISEASE; HUMANS; INHALATION; MIDDLE AGED; NEOPLASM STAGING; RADIATION INJURIES; RADIOTHERAPY; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; SPIROMETRY; VINBLASTINE; YOUNG ADULT;

EID: 79953838318     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.09.007     Document Type: Article

References (31)

1. G. Bonadonna, V. Bonfante, and S. Viviani ABVD plus subtotal nodal versus involved-field radiotherapy in early-stage Hodgkin's disease: long-term results J Clin Oncol 22 2004 2835 2841 (Pubitemid 41079901)
2. Ferme C, Eghbali H, Meerwaldt JH, et al. Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease. N Engl J Med 200;357:1916-1927.
3. E.M. Noordijk, P. Carde, and N. Dupouy Combined-modality therapy for clinical stage I or II Hodgkin's lymphoma: Long-term results of the European Organisation for Research and Treatment of Cancer H7 randomized controlled trials J Clin Oncol 24 2006 3128 3135 (Pubitemid 46638951)
4. A. Engert, J. Franklin, and H.T. Eich Two cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine plus extended-field radiotherapy is superior to radiotherapy alone in early favorable Hodgkin's lymphoma: Final results of the GHSG HD7 trial J Clin Oncol 25 2007 3495 3502 (Pubitemid 47310889)
5. K.C. Oeffinger, A.C. Mertens, and C.A. Sklar Chronic health conditions in adult survivors of childhood cancer N Engl J Med 355 2006 1572 1582 (Pubitemid 44547808)
6. T. Girinsky, and M. Ghalibafian Radiotherapy of hodgkin lymphoma: Indications, new fields, and techniques Semin Radiat Oncol 17 2007 206 222 (Pubitemid 46963032)
7. A.J. Swerdlow, C.D. Higgins, and P. Smith Myocardial infarction mortality risk after treatment for Hodgkin disease: A collaborative British cohort study J Natl Cancer Inst 99 2007 206 214
8. E.C. Moser, E.M. Noordijk, and F.E. van Leeuwen Long-term risk of cardiovascular disease after treatment for aggressive non-Hodgkin lymphoma Blood 107 2006 2912 2919
9. D.C. Hodgson, E.S. Gilbert, and G.M. Dores Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma J Clin Oncol 25 2007 1489 1497 (Pubitemid 46759253)
10. A.K. Ng, M.V. Bernardo, and E. Weller Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: Long-term risks and risk factors Blood 100 2002 1989 1996 (Pubitemid 35001228)
11. T. Girinsky, R. van der Maazen, and L. Specht Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: concepts and guidelines Radiother Oncol 79 2006 270 277 (Pubitemid 44109907)
12. T. Girinsky, C. Pichenot, and A. Beaudre Is intensity-modulated radiotherapy better than conventional radiation treatment and three-dimensional conformal radiotherapy for mediastinal masses in patients with Hodgkin's disease, and is there a role for beam orientation optimization and dose constraints assigned to virtual volumes? Int J Radiat Oncol Biol Phys 64 2006 218 226 (Pubitemid 41831230)
13. J. Yahalom Transformation in the use of radiation therapy of Hodgkin lymphoma: new concepts and indications lead to modern field design and are assisted by PET imaging and intensity modulated radiation therapy (IMRT) Eur J Haematol Suppl 2005 90 97 (Pubitemid 40873984)
14. D. Mah, J. Hanley, and K.E. Rosenzweig Technical aspects of the deep inspiration breath-hold technique in the treatment of thoracic cancer Int J Radiat Oncol Biol Phys 48 2000 1175 1185
15. T. Girinsky, L. Specht, and M. Ghalibafian The conundrum of Hodgkin lymphoma nodes: To be or not to be included in the involved node radiation fields. The EORTC-GELA lymphoma group guidelines Radiother Oncol 88 2008 202 210
16. T. Girinsky, M. Ghalibafian, and G. Bonniaud Is FDG-PET scan in patients with early stage Hodgkin lymphoma of any value in the implementation of the involved-node radiotherapy concept and dose painting? Radiother Oncol 85 2007 178 186 (Pubitemid 350160993)
17. International Commission on Radiation Units and Measurements Prescribing, recording and reporting photon beam therapy. Report 50 1999 ICRU Washington, DC
18. T. Bortfeld, S.B. Jiang, and E. Rietzel Effects of motion on the total dose distribution Semin Radiat Oncol 14 2004 41 51 (Pubitemid 38168953)
19. K.A. Goodman, S. Toner, and M. Hunt Intensity-modulated radiotherapy for lymphoma involving the mediastinum Int J Radiat Oncol Biol Phys 62 2005 198 206 (Pubitemid 40591943)
20. Engert A, Plutschow A, Eich HT, et al. Reduced treatment intensity in patients with early-stage Hodkgin's lymphoma: NEJM. 2010;363:640-652.
21. H.T. Eich, V. Diehl, and H. Gorgen Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin's lymphoma: Final analysis of the German Hodgkin Study Group HD11 trial J Clin Oncol 28 2010 4199 4206
22. A. Engert, P. Schiller, and A. Josting Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: Results of the HD8 trial of the German Hodgkin's Lymphoma Study Group J Clin Oncol 21 2003 3601 3608 (Pubitemid 46594052)
23. B.M. Aleman, J.M. Raemaekers, and R. Tomisic Involved-field radiotherapy for patients in partial remission after chemotherapy for advanced Hodgkin's lymphoma Int J Radiat Oncol Biol Phys 67 2007 19 30 (Pubitemid 44959502)
24. E.M. Noordijk, J. Thomas, and C. Ferme First results of the EORTC-GELA H9 randomized trials: the H9-F trial (comparing 3 radiation dose levels) and H9-U trial (comparing 3 chemotherapy schemes) in patients with favorable and unfavorable early stage Hodgkin lymphoma. Abstract 6505 Proc Am Soc Clin Oncol 124 2005 2005
25. L.B. Travis, D. Hill, and G.M. Dores Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma J Natl Cancer Inst 97 2005 1428 1437 (Pubitemid 41520078)
26. L.B. Travis, D.A. Hill, and G.M. Dores Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease JAMA 290 2003 465 475 (Pubitemid 37430500)
27. F.E. Van Leeuwen, W.J. Klokman, and M. Stovall Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease J Natl Cancer Inst 95 2003 971 980 (Pubitemid 36896714)
28. S. Bhatia, L.L. Robison, and O. Oberlin Breast cancer and other second neoplasms after childhood Hodgkin's disease N Engl J Med 334 1996 745 751 (Pubitemid 26089355)
29. A. Mattsson, B.I. Rudén, and P. Hall Radiation-induced breast cancer: Long-term follow-up of radiation therapy for benign breast disease J Natl Cancer Inst 85 1993 1679 1685 (Pubitemid 23315426)
30. N.G. Hildreth, R.E. Shore, and P.M. Dvoretsky The risk of breast cancer after irradiation of the thymus in infancy N Engl J Med 321 1989 1281 1284 (Pubitemid 19267213)
31. L.B. Travis, M. Gospodarowicz, and R.E. Curtis Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease J Natl Cancer Inst 94 2002 182 192 (Pubitemid 34162752)